STTR

Space Force Selects GURU, Georgia Tech, UCF to Accelerate On-Orbit Operations

Retrieved on: 
Tuesday, September 13, 2022

Example applications include repair and refueling of existing satellites, removing and recycling orbital debris, and manufacturing products in space.

Key Points: 
  • Example applications include repair and refueling of existing satellites, removing and recycling orbital debris, and manufacturing products in space.
  • With Orbital Prime, the Space Force is "finally planting a flag" and putting in real money.
  • Headquartered at the Los Angeles AFWERX hub, SpaceWERX inspires and empowers collaboration with innovators to accelerate capabilities and shape our future in space.
  • MSBAI is a privately held small business located in Los Angeles, CA, developing GURU, so you can set up simulations in minutes.

National Institute of Health (NIH) awards InfeXtious Therapeutic a Small Business Technology Transfer (STTR) grant for the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance

Retrieved on: 
Thursday, September 8, 2022

IRVINE, Calif., Sept. 8, 2022 /PRNewswire/ -- InfeXtious Therapeutic announces a Small Business Technology Transfer (STTR) grant award from the National Institute of Health (NIH). In collaboration with Dr. Rakesh Tiwari of Chapman University, the grant will support the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance.

Key Points: 
  • IRVINE, Calif., Sept. 8, 2022 /PRNewswire/ -- InfeXtious Therapeutic announces a Small Business Technology Transfer (STTR) grant award from the National Institute of Health (NIH).
  • In collaboration with Dr. Rakesh Tiwari of Chapman University, the grant will support the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance.
  • The overuse of antibiotic drugs in agriculture, aquaculture, animal feed, and medicinehas led to the development of antibiotic-resistant bacteria.
  • InfeXtious Therapeutic is a small biotechnology company with a novel cyclic peptides platform to combat antimicrobial resistance.

Aerobotix Marks 40th Restoration of Air Inlet Ducts on F-22 Raptor Aircraft

Retrieved on: 
Wednesday, August 31, 2022

Aerobotix , an AS9100-certified FANUC robotics integrator, today marked having supported the 40th restoration of air inlet ducts on F-22 Raptor aircraft, as part of a maintenance contract with the U.S. Air Force.

Key Points: 
  • Aerobotix , an AS9100-certified FANUC robotics integrator, today marked having supported the 40th restoration of air inlet ducts on F-22 Raptor aircraft, as part of a maintenance contract with the U.S. Air Force.
  • Thats a labor saving of around 80%, so it really solves the challenge of getting these aircraft back into service quicker.
  • We estimate that since 2016, weve helped the Air Force save $8.8 million $220,000 per aircraft in maintenance costs.
  • On jet aircraft, inlets ensure smooth airflow into engines despite turbulent air coming at the ducts from multiple directions.

OmniSync Incorporated Awarded a Phase II SBIR Contract by The US Air Force to Automate Contracting Processes

Retrieved on: 
Tuesday, August 30, 2022

The investigation is being conducted with collaborative feedback from the 39th and the 92nd Contracting Squadrons in the Air Force.

Key Points: 
  • The investigation is being conducted with collaborative feedback from the 39th and the 92nd Contracting Squadrons in the Air Force.
  • "We pride ourselves on developing cutting-edge innovations and are thrilled to continue our work to support the US Air Force.
  • The Air Force Research Laboratory (AFRL) is the primary scientific research and development center for the Department of the Air Force.
  • AFWERX, a program office at the Air Force Research Laboratory (AFRL), connects innovators across government, industry and academia.

South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022 World Congress on Pain

Retrieved on: 
Thursday, August 25, 2022

NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced that the Company will present a late-breaking abstract at the International Association for the Study of Pain (IASP) 2022World Congress on Pain, which will take place on September 20-23, 2022, in Toronto, Canada.

Key Points: 
  • NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced that the Company will present a late-breaking abstract at the International Association for the Study of Pain (IASP) 2022World Congress on Pain, which will take place on September 20-23, 2022, in Toronto, Canada.
  • South Rampart's CEO and Co-founder, Hernan Bazan, MD, FACS, will deliver the presentation.
  • The World Congress on Pain is the largest global gathering of pain professionals.
  • South Rampart Pharma is a clinical-stage life science company dedicated to advancing the safe treatment of pain by developing new small molecule solutions that can overcome many risks associated with current pain medicines.

South Rampart Pharma Announces Appointment of Josh Blacher as Chief Financial Officer

Retrieved on: 
Tuesday, August 16, 2022

NEW ORLEANS, Aug. 16, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced the appointment of Josh Blacher as the company's Chief Financial Officer.

Key Points: 
  • NEW ORLEANS, Aug. 16, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced the appointment of Josh Blacher as the company's Chief Financial Officer.
  • Mr. Blacher brings to South Rampart Pharma over twenty years of leadership experience in senior positions in the healthcare and capital markets sectors.
  • Hernan Bazan, M.D., F.A.C.S., CEO and Co-Founder of South Rampart Pharma and The Endowed John Ochsner Professor of Surgery at the Ochsner Clinic, commented, "We are thrilled to welcome Josh to our team.
  • "I'm elated to join the South Rampart Pharma team to help it accomplish its corporate and clinical objectives."

Florida Atlantic University enters Teaming Agreement with self-protecting, data security solution provider, Sertainty

Retrieved on: 
Thursday, August 11, 2022

NASHVILLE, Tenn., Aug. 11, 2022 /PRNewswire-PRWeb/ -- Sertainty is proud to enter into a Teaming Agreement with FAU. This agreement was awarded to Sertainty, allowing Sertainty and FAU to compete for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR.) The funding from these programs enables small businesses to explore their technological potential and incentivizes them to profit from commercialization. Now, Sertainty and FAU are partnering in the hopes of benefitting from these coveted resources.

Key Points: 
  • Florida Atlantic University (FAU) and Sertainty enter Teaming Agreement to support federal government innovation and research.
  • This agreement was awarded to Sertainty, allowing Sertainty and FAU to compete for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR.)
  • The Sertainty solution uses methods to embed security directly into data files, enabling owners to dictate who can access data, as well as where and when.
  • Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida.

Astroport Space Technologies Awarded Second NASA Technology Research Contract for Lunar Construction

Retrieved on: 
Monday, August 8, 2022

SAN ANTONIO, Aug. 8, 2022 /PRNewswire/ -- Astroport Space Technologies, Inc. has been awarded its second NASA Phase 1 Small Business Technology Transfer (STTR) contract for the construction of landing pads on the Moon.

Key Points: 
  • SAN ANTONIO, Aug. 8, 2022 /PRNewswire/ -- Astroport Space Technologies, Inc. has been awarded its second NASA Phase 1 Small Business Technology Transfer (STTR) contract for the construction of landing pads on the Moon.
  • The project will build on Astroport's previous Phase 1 STTR-21 work on regolith melting technologies and robotic bricklaying system for lunar infrastructure construction.
  • Astroport's Founder/CEO and Space Architect, Sam Ximenes said, "we are pleased that NASA continues to place confidence in our team's ability to define and develop technologies and processes for lunar infrastructure construction.
  • About Astroport:Astroport Space Technologies Inc. is a space construction and materials manufacturing company turning planetary resources into durable feedstock for autonomous construction of lunar surface infrastructure.

CPS Technologies Corporation Announces Second Quarter 2022 Results

Retrieved on: 
Thursday, August 4, 2022

NORTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) today announced revenues of $7.1 million and an operating profit of $669 thousand for the quarter ended July 2, 2022.

Key Points: 
  • NORTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) today announced revenues of $7.1 million and an operating profit of $669 thousand for the quarter ended July 2, 2022.
  • Michael McCormack, President and CEO, said: We are pleased to report that revenues in the second quarter of 2022 were the highest in the companys history and showed 6.3% improvement over revenues in the first quarter of 2022, our previous record high for a quarter.
  • Even more significantly we show a revenue increase of 21% over the second quarter of 2021.
  • Further, our second quarter operating profit represents an increase of 164% over the second quarter of 2021.

Landsdowne Labs Awarded Competitive NSF Grant to Develop Novel Battery Coating

Retrieved on: 
Tuesday, July 19, 2022

“Every year, thousands of children swallow 'button batteries' ---small, high density, coinlike batteries increasingly used in consumer devices,” said Melissa Fensterstock, the Landsdowne CEO. “Too often, the swallowed batteries cause injury to children’s internal organs, and, in some cases—death.

Key Points: 
  • Robert Langer and Jeffrey Karp, has been awarded a $256,000 grant from the National Science Foundation (NSF) to further develop and design a novel battery coating to help prevent injury and reduce risk to the thousands of children who ingest batteries each year.
  • Landsdowne is currently awaiting patent approval for its technology, and is testing the technologys efficacy, scalability, and impact on battery performance.
  • Jatana is Professor of Otolaryngology-Head and Neck surgery at Nationwide Childrens Hospital and Ohio State University and is an investor/shareholder in Landsdowne Labs.
  • In offering congratulations to Landsdowne on the NSF grant award, Robert Langer, PhD noted that the potential for children to swallow small batteries is significant and growing.